AVANT BIO

Venture firm

AVANT BIO investment thesis

Our Approach A laser focus on the enabling technologies shaping how tomorrow’s therapeutics are developed. We Are Focused We See New Opportunities We Catalyze Value We Are Focused AVANT BIO is dedicated to fueling innovative companies in the Life Sciences and Healthtech space that are developing Therapeutic-Enabling Technologies capable of making therapies more accessible and unlocking new possibilities. Thematic Focus Equitable Access to Therapies Globally Speed and Quality in Drug Discovery New Modalities, New Needs Robust, Reliable manufacturing & Supply Chain Clinical Trial Access, Diversity & Efficiency Digitization Across All Functions and Stages Innovations in Healthtech Tell Us About Your Company We See New Opportunities With our team’s over 4 decades of experience, AVANT BIO has t

AVANT BIO team (4)

Partners and principals at AVANT BIO:

Jessica Davis — sweet spot $15M
Ole Henrik Bang-Andreasen — sweet spot $15M
Daniella Kranjac — sweet spot $15M
Peter Lee — sweet spot $15M

Is AVANT BIO a fit for your round?

Upload your pitch deck and see whether anyone at AVANT BIO appears in your top matches.

Find investors for your deck